SCHEMBL6016268

SCHEMBL6016268

CCCCCc1nc(N)nc(N)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 4/20 0.53
▸ HEXA P06865 2/20 0.44
▸ HEXB P07686 2/20 0.44
▸ TLR8 Q9NR97 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ SLC22A1 O15245 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17545030 0.79 DHFR (0.54) DHFRHEXAHEXBTLR8CYP2D6
SCHEMBL28526953 0.76 DHFR (0.54) DHFRTLR8ALDH1A1MEN1HTR2A
SCHEMBL28909381 0.76 DHFR (0.54) DHFRTLR8ALDH1A1MEN1HTR2A
SCHEMBL11593834 0.75 HEXA (0.81) DHFRHEXAHEXBALDH1A1MEN1
SCHEMBL4375162 0.74 DHFR (0.49) DHFRHEXAHEXBTLR8CYP2D6
SCHEMBL1025561 0.73 DHFR (0.47) DHFRTLR8ALDH1A1MEN1KMT2A
SCHEMBL1091936 0.73 DHFR (0.47) DHFRHEXAHEXBTLR8ALDH1A1
SCHEMBL2364943 0.73 DHFR (0.47) DHFRTLR8ALDH1A1MEN1KMT2A
SCHEMBL21444633 0.73 MAPK1 (0.53) DHFRALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL12539378 0.72 KMT2A (0.43) DHFRALDH1A1MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 — — EP disclosed
EP-1534286-A1 METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS Rigel Pharmaceuticals, Inc. (US) 2005-06-01 — — EP disclosed
WO-2005012294-A1 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR USE IN THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2005-02-10 — — WO disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 — — EP disclosed
WO-2004014382-A1 METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS RIGEL PHARMACEUTICALS (US) 2004-02-19 — — WO disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 — — WO disclosed
Send feedback